Real‐Life Effectiveness of Abrocitinib and Predictors of Response in Adults With Moderate‐To‐Severe Atopic Dermatitis
Valeria Falcomatà has conflicts of interest with AbbVie and Johnson&Johnson. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Authors
- Graziella Babino (ORCID: https://orcid.org/0000-0002-5121-1743)
- Eugenia Veronica Di Brizzi (ORCID: https://orcid.org/0000-0002-0278-2443)
- Valeria Falcomatà
- Stefano Caccavale (ORCID: https://orcid.org/0000-0001-7433-9283)
- Rocco De Pasquale (ORCID: https://orcid.org/0000-0001-8644-8946)
- A. Balato
- Giampiero Mazzocchetti
- Pietro Morrone
- Giovanni Palazzo
- Claudia Giofrè
Institutions
- University of Campania "Luigi Vanvitelli" (IT)
- University of Basilicata (IT)
- University of Catania (IT)
- Azienda ospedaliera "Bianchi-Melacrino-Morelli" (IT)
- Azienda Ospedaliera di Cosenza (IT)
- Azienda USL di Pescara (IT)
- Mater Hospital (GB)
- Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte (IT)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1111/ijd.70263
- Citations
- 1
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 54.66